|
Welcome Guest
|
|
You are using Guest Account
|
|
||||||||||||||||||||||||||||||||||
|
Article 1. The present Guiding Principles are formulated for the purpose of keeping the research of human embryonic stem cell in the biomedical field of our country in line with the ethical criterion of life, ensuring the respect to and observance of internationally recognized ethical standards of life and the relevant provisions of our country, as well as promoting the healthy development of the research on human embryonic stem cell. Article 2. The human embryonic stem cell mentioned in the present Guiding Principles shall include the stem cell originated from human embryo, the stem cell originated from germ cell, and the stem cell obtained from the transplant of nucleus. Article 3. All those engaging in activities concerning the research of human embryonic stem cell within the territory of the People's Republic of China shall abide by the present Guiding Principles. Article 4. Any research on reproductive cloning is prohibited. Article 5. The human embryonic stem cell used for research may only be obtained through the following ways: (1) The unwanted gametes or blastula in vitro fertilization; (2) The fetal cells from natural abortion or voluntary abortion; (3) The blastula and asexual split blastula obtained through the technology of body nucleolus transplant; or (4) The germ cell donated on one's own initiatives. Article 6. The following criterions must be observed for making research of human embryonic stem cell: (1) For the blastulas obtained from in-vitro fertilization, transplant of body nucleolus, asexual reproduction technology or genetic modification, the time for their in-vitro breeding shall not exceed 14 days from the date of fertilization or nucleus transplant; (2) No human blastula obtained mentioned in the preceding paragraph, which has been used for research shall be transplanted into the genital system of human or any other creatures; and (3) No human germ cell may be combined with the germ cell of other species. Article 7. No human gamete, germ cell, embryo or fetus tissues may be bought or sold. Article 8. The principles of "informed consent" and "informed choice" shall be implemented earnestly for the research of human embryonic stem cell, and the informed consent letter shall be signed to protect the privacy of the test person (TP). The "informed consent" and "informed choice" mentioned in the preceding paragraph mean that the researchers shall, before making the experiments, tell the test persons according to facts the aim and the results and risks possibly occur in accurate, clear and popular language, and sign the informed consent letters with them after gaining their consent. Article 9. The entities engaging in the research of human embryonic stem cell shall set up an ethic committee consisting of researchers and managers in the relevant fields including biology, medicine, law, or sociology, etc., whose function is to make overall examination, consultation and supervision over the ethic and science groundings of the research of human embryonic stem cell. Article 10. The entities engaging in the research of human embryonic stem cell shall formulate implementation rules or administration regulations of their own in pursuance of the present Guiding Principles accordingly. Article 11. The administrative department in charge of science and technology and public health of the State Council shall be responsible for the interpretation of the present Guiding Principles. Article 12. The present Guiding Principles shall be implemented as of their promulgation. |
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
Copyright 2002 NovexCn.com
|